Dabomb Protein (6578) — Cash Flow-to-Debt Ratio
Dabomb Protein (6578) has a Cash Flow-to-Debt Ratio of 0.00x as of December 2025, meaning its operating cash flow of NT$-354.00K could theoretically repay 0% of its total liabilities (NT$106.48 Million) in one year. See free cash flow generation of Dabomb Protein to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Dabomb Protein Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Dabomb Protein across 11 annual periods. Also explore Dabomb Protein annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Dabomb Protein (2015–2025)
Year-by-year debt coverage analysis for Dabomb Protein. For market capitalisation and broader financial context, see 6578 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | NT$16.65 Million | NT$106.48 Million | ▼ -25.7% |
| 2024 | 0.21x | NT$47.55 Million | NT$225.96 Million | ▲ +1335.7% |
| 2023 | 0.01x | NT$6.51 Million | NT$443.83 Million | ▼ -58.9% |
| 2022 | 0.04x | NT$19.71 Million | NT$552.88 Million | ▲ +153.3% |
| 2021 | -0.07x | NT$-44.25 Million | NT$662.24 Million | ▼ -277.7% |
| 2020 | 0.04x | NT$13.41 Million | NT$356.66 Million | ▼ -75.0% |
| 2019 | 0.15x | NT$33.26 Million | NT$220.96 Million | ▼ -10.4% |
| 2018 | 0.17x | NT$22.07 Million | NT$131.39 Million | ▼ -12.6% |
| 2017 | 0.19x | NT$43.87 Million | NT$228.29 Million | ▼ -35.5% |
| 2016 | 0.30x | NT$59.58 Million | NT$200.11 Million | ▼ -70.8% |
| 2015 | 1.02x | NT$139.78 Million | NT$137.31 Million | — |